[go: up one dir, main page]

NO940144L - 2-(4-hydroksypiperidino)1-alkanolderivater som antiiskemiske midler - Google Patents

2-(4-hydroksypiperidino)1-alkanolderivater som antiiskemiske midler

Info

Publication number
NO940144L
NO940144L NO940144A NO940144A NO940144L NO 940144 L NO940144 L NO 940144L NO 940144 A NO940144 A NO 940144A NO 940144 A NO940144 A NO 940144A NO 940144 L NO940144 L NO 940144L
Authority
NO
Norway
Prior art keywords
hydroxypiperidino
chemical agents
alkanol derivatives
alkanol
derivatives
Prior art date
Application number
NO940144A
Other languages
English (en)
Other versions
NO940144D0 (no
NO180445B (no
NO180445C (no
Inventor
Willard Mckowan Welch Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO940144D0 publication Critical patent/NO940144D0/no
Publication of NO940144L publication Critical patent/NO940144L/no
Publication of NO180445B publication Critical patent/NO180445B/no
Publication of NO180445C publication Critical patent/NO180445C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO940144A 1991-07-17 1994-01-14 2-(4-hydroksypiperidino)-1-alkanol-derivater som anti-iskemiske midler NO180445C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73157791A 1991-07-17 1991-07-17
PCT/US1992/004973 WO1993002052A1 (en) 1991-07-17 1992-06-19 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents

Publications (4)

Publication Number Publication Date
NO940144D0 NO940144D0 (no) 1994-01-14
NO940144L true NO940144L (no) 1994-01-14
NO180445B NO180445B (no) 1997-01-13
NO180445C NO180445C (no) 1997-04-23

Family

ID=24940103

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940144A NO180445C (no) 1991-07-17 1994-01-14 2-(4-hydroksypiperidino)-1-alkanol-derivater som anti-iskemiske midler

Country Status (22)

Country Link
EP (1) EP0594729A1 (no)
JP (1) JP2571904B2 (no)
KR (1) KR0165003B1 (no)
CN (1) CN1043759C (no)
AU (1) AU655840B2 (no)
BR (1) BR9206272A (no)
CA (1) CA2113568A1 (no)
CZ (1) CZ284133B6 (no)
EG (1) EG20048A (no)
FI (2) FI981956L (no)
HU (1) HUT70528A (no)
IE (1) IE922311A1 (no)
IL (1) IL102473A (no)
MX (1) MX9204190A (no)
NO (1) NO180445C (no)
NZ (1) NZ243580A (no)
PL (1) PL169884B1 (no)
PT (1) PT100689B (no)
RU (1) RU2065859C1 (no)
TW (1) TW201732B (no)
WO (1) WO1993002052A1 (no)
ZA (1) ZA925306B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
DK0666854T3 (da) * 1992-10-30 1997-04-28 Pfizer Neurobeskyttende 3,4-dihydro-2(1H)-quinolon forbindelser
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
US6978166B2 (en) 1994-10-07 2005-12-20 Saint Louis University System for use in displaying images of a body part
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
CA2220649C (en) * 1996-12-03 2007-02-13 F. Hoffmann-La Roche Ag 4-hydroxy-piperidine derivatives
EP1182193A4 (en) * 1999-04-09 2002-09-11 Mochida Pharm Co Ltd REMEDIES FOR NEUROGENIC PAIN
TWI254043B (en) * 1999-06-08 2006-05-01 Hoffmann La Roche Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
WO2001030330A2 (en) 1999-10-29 2001-05-03 Merck Sharp & Dohme Limited Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
US6316474B1 (en) 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
US6291499B1 (en) 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
US6489477B1 (en) 1999-10-29 2002-12-03 Merck & Co., Inc. 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
US6380205B1 (en) 1999-10-29 2002-04-30 Merck & Co., Inc. 2-cyclohexyl quinazoline NMDA/NR2B antagonists
US6432976B1 (en) 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
EA005974B1 (ru) 2001-02-23 2005-08-25 Мерк Энд Ко., Инк. N-замещенные неарильные гетероциклические антагонисты nmda/nr2b
US7259157B2 (en) 2001-04-03 2007-08-21 Merck & Co., Inc. N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
JP4544999B2 (ja) 2002-11-25 2010-09-15 持田製薬株式会社 ４−ヒドロキシピペリジン誘導体を有効成分とする呼吸器疾患治療剤
BRPI0415113A (pt) * 2003-10-08 2006-11-28 Pfizer compostos de lactama condensados
TWI409289B (zh) 2010-09-02 2013-09-21 Taiwan Union Technology Corp 由氮氧雜環化合物所製得之聚合物之穩態溶液及其製法與用途
EP4168116A4 (en) * 2020-06-23 2024-07-10 Biohaven Therapeutics Ltd. Topical formulations of (1s)-1-phenyl-2-pyridin-2-ylethanamine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2546166B1 (fr) * 1983-05-19 1985-10-25 Synthelabo Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
ES2098248T3 (es) * 1989-05-17 1997-05-01 Pfizer Derivados de 2-piperidino-1-alcanoles como agentes antiisquemicos.
EP0554247B1 (en) * 1990-05-10 2000-04-26 Pfizer Inc. Neuroprotective indolone and related derivatives

Also Published As

Publication number Publication date
PT100689A (pt) 1993-10-29
ZA925306B (en) 1994-01-17
WO1993002052A1 (en) 1993-02-04
JP2571904B2 (ja) 1997-01-16
AU2322592A (en) 1993-02-23
PL169884B1 (pl) 1996-09-30
MX9204190A (es) 1993-01-01
RU2065859C1 (ru) 1996-08-27
NO940144D0 (no) 1994-01-14
NO180445B (no) 1997-01-13
CN1068566A (zh) 1993-02-03
AU655840B2 (en) 1995-01-12
FI981956A0 (fi) 1998-09-11
BR9206272A (pt) 1995-04-11
CZ284133B6 (cs) 1998-08-12
IL102473A (en) 1997-07-13
CA2113568A1 (en) 1993-02-04
CN1043759C (zh) 1999-06-23
JPH06504293A (ja) 1994-05-19
NO180445C (no) 1997-04-23
NZ243580A (en) 1994-10-26
EG20048A (en) 1997-03-27
IE922311A1 (en) 1993-01-27
FI981956A7 (fi) 1998-09-11
FI940192A0 (fi) 1994-01-14
FI981956L (fi) 1998-09-11
HU9400136D0 (en) 1994-05-30
EP0594729A1 (en) 1994-05-04
CZ400892A3 (en) 1994-03-16
HUT70528A (en) 1995-10-30
PT100689B (pt) 1999-06-30
IL102473A0 (en) 1993-01-14
FI940192L (fi) 1994-01-14
TW201732B (no) 1993-03-11
KR0165003B1 (en) 1999-01-15
FI940192A7 (fi) 1994-01-14

Similar Documents

Publication Publication Date Title
NO940144L (no) 2-(4-hydroksypiperidino)1-alkanolderivater som antiiskemiske midler
FI921675L (fi) En detergentsammansaettning innehaollande polyimidbiopolymer som blir hydrolyserad i tvaettningsvatten
FI924091A7 (fi) Autoriseringsprotokoll som foersiktighetshjaelpmedel
FI933167A0 (fi) N-alkylkinuklidiniumsalter som substans-p antagonister
FI924982A0 (fi) Frystorkat preparat som innehaoller monoklonal motkropp
FI930836L (fi) Topiska preparat som innehaoller cyklosporin
FI921556L (fi) Plasttillslutning som visar otillboerlig anvaendning
FI921182L (fi) Velangummi som snabbt hydratiseras
DK0516349T3 (da) 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister
FI925526A0 (fi) Kontrastmedel foer ultraljudsavbildning
FI935842A7 (fi) Anvaendning av tetrahydrokarbazonderivat som 5ht1 -reseptoragonister
FI934225L (fi) Bis-naftalimider innehaollande ur aminosyror haerledda kopplingsaemnen som anticancermedel
DK0551048T3 (da) 2-Imidazon-5-on- og 2-imidazolin-5-thion-derivater som fungicider
FI935944L (fi) Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer
FI925330L (fi) Substituerade fenylfenoler som leukotrienantagonister
FI924571L (fi) Foerfarande foer binaer kodning av punkter i en punktgrupp som anvaends i multibaervaogsmodulering av ofdm-typ
FI923382A7 (fi) Laosanordning som omfattar nyckel och laoscylinder
FI921974A7 (fi) Lageranlaeggning och undervattensdrivdraftsenhet som innehaoller den
FI925295L (fi) Baenksystem foer kompositioner avsedda foer jordbruk
DE69209099D1 (de) Sulfonamidderivate
FI934017A7 (fi) Vaermeanordning som anvaender fast braensle
FI921666L (fi) Indolin- och dihydrokinolinfoereningar som oeppnare av kaliumkanal
FI923555L (fi) Foerfarande foer framstaellning av mattor som bestaor av minst tvao med varandra bundna skikt
FI930342L (fi) Pentapeptider som reglerar immun- och nervsystem
FI935867L (fi) Tetrahydrobensazepinderivat som inhibiterar lipoxigenas

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2001